PW Medtech Group Beheer

Hoe is Yue'e Zhang's beloning veranderd ten opzichte van PW Medtech Group's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	CN¥152m
Mar 31 2024	n/a	n/a	CN¥153m
Dec 31 2023	CN¥1m	CN¥1m	CN¥153m
Sep 30 2023	n/a	n/a	CN¥135m
Jun 30 2023	n/a	n/a	CN¥116m
Mar 31 2023	n/a	n/a	CN¥111m
Dec 31 2022	CN¥1m	CN¥1m	CN¥106m
Sep 30 2022	n/a	n/a	CN¥72m
Jun 30 2022	n/a	n/a	CN¥39m
Mar 31 2022	n/a	n/a	CN¥389m
Dec 31 2021	CN¥1m	CN¥1m	CN¥739m
Sep 30 2021	n/a	n/a	CN¥995m
Jun 30 2021	n/a	n/a	CN¥1b
Mar 31 2021	n/a	n/a	CN¥942m
Dec 31 2020	CN¥1m	CN¥1m	CN¥632m
Sep 30 2020	n/a	n/a	CN¥398m
Jun 30 2020	n/a	n/a	CN¥163m
Mar 31 2020	n/a	n/a	CN¥123m
Dec 31 2019	CN¥1m	CN¥1m	CN¥82m
Jun 30 2019	n/a	n/a	CN¥136m
Mar 31 2019	n/a	n/a	CN¥126m
Dec 31 2018	CN¥995k	CN¥995k	CN¥115m
Jun 30 2018	n/a	n/a	CN¥27m
Mar 31 2018	n/a	n/a	CN¥16m
Dec 31 2017	CN¥1m	CN¥1m	CN¥5m

Compensatie versus markt: De totale vergoeding ($USD 149.13K ) Yue'e } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 359.95K ).

Compensatie versus inkomsten: De vergoeding van Yue'e is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Yue'e Zhang (61 yo)

5.7yrs

Tenure

CN¥1,062,000

Compensatie

Ms. Yue'e Zhang has been Chief Executive Officer at PW Medtech Group Ltd. since March 31, 2019. Ms. Zhang serves as a General Manager, Senior Engineer and Executive Director of WP Medical Technologies, Inc...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Yue'e Zhang	Executive Chairman & CEO	5.7yrs	CN¥1.06m	geen gegevens
Tian Tian	Financial Director	4.8yrs	geen gegevens	geen gegevens
Ka Man So	Company Secretary	2.3yrs	geen gegevens	geen gegevens

4.8yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 1358 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Yue'e Zhang	Executive Chairman & CEO	13.5yrs	CN¥1.06m	geen gegevens
Xiaogang Wang	Independent Non-Executive Director	11.1yrs	CN¥181.00k	geen gegevens
Geng Chen	Independent Non-Executive Director	11.1yrs	CN¥181.00k	0.042% HK$ 681.5k
Liwei Jiang	Non-Executive Director	11.4yrs	CN¥300.00k	0.17% HK$ 2.8m
Junshan Lin	Non-Executive Director	11.4yrs	CN¥300.00k	0.11% HK$ 1.8m
Fengli Wang	Independent Non-Executive Director	3.3yrs	CN¥181.00k	geen gegevens

11.3yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 1358 zijn ervaren en ervaren (gemiddelde ambtstermijn van 11.3 jaar).

PW Medtech Group Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Insufficient new directors

Executive Chairman & CEO recently sold HK$53k worth of stock

Here's Why PW Medtech Group Limited's (HKG:1358) CEO Might See A Pay Rise Soon

PW Medtech Group Limited, Annual General Meeting, Jun 14, 2024

PW Medtech Group Limited Announces Executive Changes

PW Medtech Group Limited, Annual General Meeting, Jun 08, 2022

Recent updates

Upcoming dividend of HK$0.045 per share

PW Medtech Group's (HKG:1358) Solid Earnings Are Supported By Other Strong Factors

Insufficient new directors

PW Medtech Group Limited to Report First Half, 2024 Results on Aug 30, 2024

Now 21% overvalued after recent price rise

Upcoming dividend of HK$0.05 per share

Executive Chairman & CEO recently sold HK$53k worth of stock

Here's Why PW Medtech Group Limited's (HKG:1358) CEO Might See A Pay Rise Soon

PW Medtech Group Limited (SEHK:1358) announces an Equity Buyback for HKD 150 million worth of its shares.

PW Medtech Group Limited, Annual General Meeting, Jun 14, 2024

Full year 2023 earnings released: EPS: CN¥0.098 (vs CN¥0.068 in FY 2022)

PW Medtech Group Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

There's Reason For Concern Over PW Medtech Group Limited's (HKG:1358) Price

Upcoming dividend of HK$0.049 per share at 11% yield

PW Medtech Group Limited Announces Interim (Semi-Annual) Dividend for the Six Months Ended 30 June 2023, Payable on October 24, 2023

PW Medtech Group Limited Announces Interim (Semi-Annual) Dividend for the Six Months Ended 30 June 2023, Payable on October 24, 2023

PW Medtech Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023

PW Medtech Group Limited to Report First Half, 2023 Results on Aug 31, 2023

New minor risk - Market cap size

Full year 2022 earnings released: EPS: CN¥0.068 (vs CN¥0.47 in FY 2021)

We Think PW Medtech Group (HKG:1358) Can Manage Its Debt With Ease

First half 2022 earnings released: EPS: CN¥0.039 (vs CN¥0.48 in 1H 2021)

PW Medtech Group Limited Announces Executive Changes

PW Medtech Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

PW Medtech Group Limited to Report First Half, 2022 Results on Aug 31, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

PW Medtech Group Limited, Annual General Meeting, Jun 08, 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

PW Medtech Group Limited (SEHK:1358) agreed to acquire 51.5% stake in Beijing Ruijian High-Tech Biological Technology Co., Ltd from a group of shareholders for CNY 412 million.

First half 2021 earnings released: EPS CN¥0.48 (vs CN¥0.09 in 1H 2020)

Investor sentiment improved over the past week

Independent Non-Executive Director Xingdong Zhang has left the company

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.40 (vs CN¥0.052 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.40 (vs CN¥0.052 in FY 2019)

PW Medtech Group Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

How Much Have PW Medtech Group (HKG:1358) Shareholders Earned On Their Investment Over The Last Five Years?

New 90-day low: HK$0.52

Should You Rely On PW Medtech Group's (HKG:1358) Earnings Growth?

New 90-day high: HK$2.31

CITIC Capital Holdings Limited completed the acquisition of 2.4% stake in China Biologic Products Holdings, Inc. (NasdaqGS:CBPO) from PW Medtech Group Limited (SEHK:1358).

Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly

Should You Be Adding PW Medtech Group (HKG:1358) To Your Watchlist Today?

New 90-day high: HK$2.29

What You Need To Know About PW Medtech Group Limited's (HKG:1358) Investor Composition

Market bids up stock over the past week

CITIC Capital Holdings Limited entered into an agreement to acquire 2.4% stake in China Biologic Products Holdings, Inc. (NasdaqGS:CBPO) from PW Medtech Group Limited (SEHK:1358) for approximately $110 million.

New 90-day high: HK$1.76

First half earnings released

PW Medtech Group Limited to Report First Half, 2020 Results on Aug 27, 2020

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd